|
|
|
Volumn 47, Issue 1203, 2005, Pages 19-20
|
|
Two once-daily fixed-dose NRTI combinations for HIV
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
ABACAVIR PLUS LAMIVUDINE;
ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
EFAVIRENZ;
EMTRICITABINE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
LAMIVUDINE;
LAMIVUDINE PLUS ZIDOVUDINE;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
TENOFOVIR;
ZIDOVUDINE;
ABACAVIR LAMIVUDINE COMBINATION;
ABACAVIR-LAMIVUDINE COMBINATION;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
ORGANOPHOSPHORUS COMPOUND;
ADJUVANT THERAPY;
DIARRHEA;
DRUG COST;
DRUG DOSE REGIMEN;
DRUG HYPERSENSITIVITY;
DRUG MECHANISM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
SHORT SURVEY;
ARTICLE;
DOSE RESPONSE;
DRUG COMBINATION;
ANTI-HIV AGENTS;
DEOXYCYTIDINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG COMBINATIONS;
DRUG HYPERSENSITIVITY;
HIV INFECTIONS;
HUMANS;
LAMIVUDINE;
ORGANOPHOSPHORUS COMPOUNDS;
|
|
EID: 14844293937
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (4)
|
|
References (5)
|
